Information message

In order to see all the search results and access content, you must log in. Please use the Log-in button at the top of the page.

Displaying 133 - 144 of 431

EASL Studio S3 E12: Meeting the challenge of antimicrobial resistance (AMR) in cirrhosis: the invisible threat that lies within

Description

Antimicrobial resistance (AMR) is growing problem that greatly impacts treatment outcome. In this episode the faculty discuss:

  • The impact of prescribing antibiotics as primary and secondary prophylaxis on AMR rates
  • What can be done globally to reduce AMR rates

Faculty

  • Prof. Debbie Shawcross (Moderator)
  • Prof. Jonel Trebicka (Moderator)
  • Prof. Jasmohan Bajaj (Faculty)
  • Dr Lindsey Edwards (Faculty)
  • Dr Benedikt Huttner (Faculty, WHO representative)

ℹ️ Please click here to access the podcast version of this EASL Studio episode.

 

Log in to post comments

EASL Studio S4 E13: JHEP Live: Liver transplantation for alcohol-related hepatitis

Description

The topic of liver transplantation for alcohol-related hepatitis is controversial. While some experts still recommend 6 months of alcohol abstinence before considering transplantation others advocate for early transplantation.

Watch this episode to:

  • Understand the epidemiology of alcohol-related hepatitis.
  • Know which treatment options are available to these patients
  • Find out which patients may benefit from earl liver transplantation.

Faculty

  • Prof. Patrizia Burra (Moderator)
  • Dr Giacomo Germani (Faculty)
  • Prof. Alexandre Louvet (Faculty)

Related episodes

ℹ️ Please click here to access the podcast version of this EASL Studio episode.

 

Log in to post comments
General Hepatology
EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy

EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy

PDF
View
General Hepatology
Online Courses

Online Courses

View
Cirrhosis & Complications
Quiz: A 46-year-old man is admitted with a new diagnosis of cirrhosis and ascites of unclear aetiology.

Quiz: A 46-year-old man is admitted with a new diagnosis of cirrhosis and ascites of unclear aetiology.

Quiz
View
Viral Hepatitis
EASL Clinical Practice Guidelines on hepatitis delta virus

EASL Clinical Practice Guidelines on hepatitis delta virus

PDF
View
Metabolism, Alcohol & Toxicity
Non-alcoholic fatty liver disease: A patient guideline - GE version

Non-alcoholic fatty liver disease: A patient guideline - GE version

PDF
View
Metabolism, Alcohol & Toxicity
Non-alcoholic fatty liver disease: A patient guideline

Non-alcoholic fatty liver disease: A patient guideline

PDF
View
Metabolism, Alcohol & Toxicity
EASL Policy Statement: Reducing alcohol harms

EASL Policy Statement: Reducing alcohol harms

PDF
View
Liver Tumours
EASL Policy Statement: risk-based surveillance for hepatocellular carcinoma among patients with cirrhosis

EASL Policy Statement: risk-based surveillance for hepatocellular carcinoma among patients with cirrhosis

PDF
View

EASL Studio S2 E8: Treatment of HBV-HDV coinfection in the era of entry inhibition

Description

In this episode of EASL studio, learn about the clinical management and treatment of hepatitis D infection in the era of emerging treatments.

  • What does the clinical management of Hepatitis Delta infection look like in the era of emerging new treatments?
  • What is the prevalence of anti-HDV and HDV RNA positivity?
  • How do you manage HBV-HDV co-infected patients?

This project has been made possible with the provision of a financial grant from Gilead Sciences Europe Ltd. 

EASL has received no input from Gilead with regards to the content of this programme.

ℹ️ Please click here to access the podcast version of this EASL Studio episode.

 

Moderator

 
Magdalena Filipowicz Sinnreich PD. Dr. med. Dr. phil. Magdalena Filipowicz Sinnreich is the head of the Liver Immunology Laboratory at the Department of Biomedicine of the University Hospital in Basel, Switzerland, and the head of the liver service at the Gastroenterology Department of the Kantonsspital Baselland, a hospital affiliated with the University of Basel. She is a lecturer in hepatology and basic science at the University of Basel. She has published in numerous peer reviewed journals on Hepatitis C virus infection and liver immunology. She is a recipient of the Pfizer Research Prize in Switzerland, the Senior Hepatology Prize of the Swiss Society of Gastroenterology, and the EASL Sheila Sherlock Postdoctoral Fellowship award. She is an advocate for women in science and women in hepatology.

Faculty

 
Pietro Lampertico

Professor Pietro Lampertico is Full Professor in the Gastroenterology, Director of the Gastroenterology and Hepatology Division. He is also head of the “A. M. e A. Migliavacca” Center for Liver Disease at the Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, University of Milan, Milan, Italy. In the Gastroenterology Unit, Professor Lampertico is primarily involved in the clinical management of chronic viral hepatitis outpatients, particularly those with CHB and CHD. His research interests include the treatment of patients with chronic hepatitis/cirrhosis due to HBV and HDV, the long-term outcome of cirrhotic patients undergoing antiviral treatment, and the diagnosis and management of antiviral resistance to oral nucleos(t)ide analogues.

Heiner Wedemeyer

Heiner Wedemeyer is Professor and Chairman of the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School since April 1, 2020. His long-term research interest is in liver diseases with special focus on viral hepatitis, liver transplantation and hepatocellular carcinoma. He has been principal investigator in numerous clinical trials, focusing on antiviral therapy and immunotherapy of viral hepatitis B, C, D and E. Heiner Wedemeyer is member of several scientific organizations and was Secretary General of the European Association for the Study of the Liver from 2009 to 2011.

Log in to post comments
Liver Tumours
Liver Cancer Explained

Liver Cancer Explained

Infographics
View